We aim to elucidate the molecular mechanism by which PIN1 and CDK1 cooperatively modulate pVHL stability, contribute to tumor progression and explore their therapeutic potential in the treatment of cancers with wild-type VHL including TNBC. This evidence concerns the gene CDK1 and cancer.